Actively Recruiting
Evaluating Extra-Virgin Olive Oil Supplementation During Cardiac Rehabilitation for Heart Failure With Reduced Ejection Fraction
Led by Old Dominion University · Updated on 2026-10-16
40
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether daily supplementation with extra-virgin olive oil EVOO during a cardiac rehabilitation program is feasible for patients with heart failure with reduced ejection fraction HFrEF. This study aims to evaluate the effects of EVOO on patients functional capacity and quality of life over a 12-week period. Participants will be randomly assigned to receive at least 4 tablespoons of extra-virgin olive oil daily in addition to their standard cardiac rehabilitation care or to continue with standard care alone. The study compares these groups to determine dietary compliance and changes in monounsaturated fatty acid intake. Throughout the study, participants will be assessed at baseline and after 12 weeks for changes in dietary intake, plasma fatty acid levels, walking ability measured by a 6-minute walk test, and quality of life using a specific questionnaire. The study measures the impact of EVOO supplementation alongside routine rehabilitation over the 12-week timeframe.
CONDITIONS
Brief Title
Olive Oil Supplementation for Heart Failure With Reduced Ejection Fraction
Research Team
S
Salvatore Carbone, PhD, RDN
S
Saiful Anuar Bin Singar, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here